Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #2 of 6 in 2019

Macquarie University Centre for the Health Economy; Martin Hoyle

Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #2 of 6 in 2019

Macquarie University Centre for the Health Economy, Martin Hoyle

Research output: Book/Report › Other report

Original language	English
Publisher	Australian Government Department of Health
Publication status	Published - 2019

Cite this

@book{77e328cf3f984307b1dfa0df07694152,

title = "Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #2 of 6 in 2019",

author = "{Macquarie University Centre for the Health Economy} and Martin Hoyle",

year = "2019",

language = "English",

publisher = "Australian Government Department of Health",

}

TY - BOOK

T1 - Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #2 of 6 in 2019

AU - Macquarie University Centre for the Health Economy

AU - Hoyle, Martin

PY - 2019

Y1 - 2019

M3 - Other report

BT - Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #2 of 6 in 2019

PB - Australian Government Department of Health

ER -